# Treatment of Multiple Sclerosis Using Over the Counter Inosine

> **NCT00067327** · PHASE2 · COMPLETED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)** · enrollment: 30 (—)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **DRUG:** Inosine

## Key facts

- **NCT ID:** NCT00067327
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 30 (—)
- **Last updated:** 2006-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00067327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00067327, "Treatment of Multiple Sclerosis Using Over the Counter Inosine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00067327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*